meglumine has been researched along with dacarbazine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N | 1 |
Choi, CG; Kim, C; Kim, HS; Kim, JH; Kim, SJ; Shim, WH | 1 |
1 review(s) available for meglumine and dacarbazine
Article | Year |
---|---|
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Mechlorethamine; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine | 1991 |
2 other study(ies) available for meglumine and dacarbazine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Recurrent Glioblastoma: Combination of High Cerebral Blood Flow with MGMT Promoter Methylation Is Associated with Benefit from Low-Dose Temozolomide Rechallenge at First Recurrence.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Blood Volume; Brain Neoplasms; Cerebrovascular Circulation; Combined Modality Therapy; Contrast Media; Dacarbazine; Disease Progression; Female; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; O(6)-Methylguanine-DNA Methyltransferase; Organometallic Compounds; Polymerase Chain Reaction; Retrospective Studies; Temozolomide; Treatment Outcome | 2017 |